{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:36:35Z","timestamp":1788629795430,"version":"build-2803163510"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["740608"],"award-info":[{"award-number":["740608"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17152116"],"award-info":[{"award-number":["17152116"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17121419"],"award-info":[{"award-number":["17121419"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["766211"],"award-info":[{"award-number":["766211"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015186","name":"Gaia Family Trust, New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","award":["200006276"],"award-info":[{"award-number":["200006276"]}],"id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","award":["104004092"],"award-info":[{"award-number":["104004092"]}],"id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","award":["104004460"],"award-info":[{"award-number":["104004460"]}],"id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["21222101"],"award-info":[{"award-number":["21222101"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["15162961"],"award-info":[{"award-number":["15162961"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["18192141"],"award-info":[{"award-number":["18192141"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["16172751"],"award-info":[{"award-number":["16172751"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phrs.2025.108049","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:23:37Z","timestamp":1764001417000},"page":"108049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The role of Chinese medicines in targeting non-coding RNAs to overcome cancer drug resistance: Mechanisms and clinical translation challenges"],"prefix":"10.1016","volume":"222","author":[{"given":"Guoming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qili","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengya","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2430-7934","authenticated-orcid":false,"given":"Bonan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0241-670X","authenticated-orcid":false,"given":"Yibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.108049_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CaCancer J. Clin."},{"key":"10.1016\/j.phrs.2025.108049_bib2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.108049_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metast Rev."},{"key":"10.1016\/j.phrs.2025.108049_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"Perez-Gonzalez","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.phrs.2025.108049_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2025.108049_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.108049_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13020-019-0270-9","article-title":"Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine","volume":"14","author":"Luo","year":"2019","journal-title":"Chin. MedUk"},{"key":"10.1016\/j.phrs.2025.108049_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","article-title":"Traditional Chinese medicine in lung cancer treatment","volume":"24","author":"Xi","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1429483","article-title":"Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors","volume":"15","author":"Guo","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.108049_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153184","article-title":"\u03b2-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323\/Cbl-b\/EGFR pathway","volume":"69","author":"Deng","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.108049_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3032407","article-title":"Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1\/miR-200s\/JNK Signaling Pathway","volume":"2022","author":"Wei","year":"2022","journal-title":"Evid. Based Compl Alt."},{"key":"10.1016\/j.phrs.2025.108049_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ca.24057","article-title":"Curcumin inhibits colon cancer malignant progression and promotes T cell killing by regulating miR-206 expression","volume":"37","author":"Tong","year":"2024","journal-title":"Clin. Anat."},{"key":"10.1016\/j.phrs.2025.108049_bib14","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1007\/s00210-024-03736-x","article-title":"Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance","volume":"398","author":"Elimam","year":"2025","journal-title":"N. S Arch. Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cac2.12138","article-title":"EMT-associated microRNAs and their roles in cancer stemness and drug resistance","volume":"41","author":"Pan","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.phrs.2025.108049_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106418","article-title":"Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy","volume":"184","author":"Hashemi","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2025.108049_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70333","article-title":"Epithelial-Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications","volume":"6","author":"Srinivasan","year":"2025","journal-title":"Medcomm"},{"key":"10.1016\/j.phrs.2025.108049_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2025.108049_bib19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Gene Dev."},{"key":"10.1016\/j.phrs.2025.108049_bib20","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.08.011","article-title":"Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205","volume":"181","author":"Puhr","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2025.108049_bib21","article-title":"Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer","volume":"22","author":"Kim","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104516","article-title":"Reawakening the master switches in triple-negative breast cancer: A strategic blueprint for confronting metastasis and chemoresistance via microRNA-200\/205: A systematic review","volume":"204","author":"Ahmadi-Hadad","year":"2024","journal-title":"Crit. Rev. Oncol. Hemat"},{"key":"10.1016\/j.phrs.2025.108049_bib23","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41416-021-01568-7","article-title":"Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC","volume":"125","author":"Garinet","year":"2021","journal-title":"Brit J. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGFbeta biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114692","article-title":"MicroRNA-495\/TGF-beta\/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells","volume":"192","author":"Kumar","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41571-025-01059-1","article-title":"Understanding and overcoming multidrug resistance in cancer","volume":"22","author":"Ge","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-022-01306-3","article-title":"Long noncoding RNA Smyca coactivates TGF-beta\/Smad and Myc pathways to drive tumor progression","volume":"15","author":"Chen","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib28","article-title":"Transforming Growth Factor-Beta-Regulated LncRNA-MUF Promotes Invasion by Modulating the miR-34a Snail1 Axis in Glioblastoma Multiforme","volume":"11","author":"Shree","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","article-title":"Wnt\/beta-catenin-driven EMT regulation in human cancers","volume":"81","author":"Xue","year":"2024","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12943-021-01455-y","article-title":"Long non-coding RNA NORAD\/miR-224-3p\/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of beta-catenin","volume":"20","author":"Jia","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12943-022-01555-3","article-title":"Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m(6)A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41419-021-04339-7","article-title":"EIF4A3-induced circular RNA PRKAR1B promotes osteosarcoma progression by miR-361-3p-mediated induction of FZD4 expression","volume":"12","author":"Feng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-025-02259-0","article-title":"C. Hsa_circ_0125356 promotes gemcitabine resistance by modulating WNT canonical and non-canonical pathways via miR-582-5p\/FGF9 axis in non-small cell lung cancer","volume":"24","author":"Luo","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102054","article-title":"MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K\/AKT pathway","volume":"34","author":"Obata","year":"2023","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.phrs.2025.108049_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102125","article-title":"MicroRNA-376a-3p sensitizes CPT-11-resistant colorectal cancer by enhancing apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) through the IGF1R\/PI3K\/AKT pathway","volume":"50","author":"Jassi","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib36","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41388-025-03306-2","article-title":"The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma","volume":"44","author":"Piao","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2025.108049_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13046-021-02137-9","article-title":"M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239307","article-title":"Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines","volume":"21","author":"Haque","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12964-024-01643-5","article-title":"Signaling, cancer cell plasticity, and intratumor heterogeneity","volume":"22","author":"Cordani","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.phrs.2025.108049_bib40","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.7150\/thno.41648","article-title":"Stem cell programs in cancer initiation, progression, and therapy resistance","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2025.108049_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7150\/ijbs.74227","article-title":"miR-1275 targets MDK\/AKT signaling to inhibit breast cancer chemoresistance by lessening the properties of cancer stem cells","volume":"19","author":"Han","year":"2023","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031626","article-title":"Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer","volume":"23","author":"Coradduzza","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2418096121","article-title":"Loss of XIST lncRNA unlocks stemness and cellular plasticity in ovarian cancer","volume":"121","author":"Naciri","year":"2024","journal-title":"P Natl. Acad. Sci. Usa"},{"key":"10.1016\/j.phrs.2025.108049_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13045-021-01194-z","article-title":"A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002232","article-title":"A Novel Long Non-Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis","volume":"8","author":"Qin","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/1878-0261.13735","article-title":"CASCADES, a novel SOX2 super-enhancer-associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma","volume":"19","author":"Shahzad","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41419-022-04707-x","article-title":"UPF1 contributes to the maintenance of endometrial cancer stem cell phenotype by stabilizing LINC00963","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-024-02983-3","article-title":"ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia","volume":"43","author":"Lin","year":"2024","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41523-022-00484-0","article-title":"LINC00589-dominated ceRNA networks regulate multiple chemoresistance and cancer stem cell-like properties in HER2(+) breast cancer","volume":"8","author":"Bai","year":"2022","journal-title":"Npj Breast Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib50","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1186\/s12885-023-11571-1","article-title":"Circular RNA ZNF800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer","volume":"23","author":"Rengganaten","year":"2023","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib51","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1038\/s41388-025-03482-1","article-title":"Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1\/circCDR1-AS\/miR-1290\/BMP4 signaling","volume":"44","author":"Huo","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2025.108049_bib52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12951-024-02760-6","article-title":"Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer","volume":"22","author":"Fei","year":"2024","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.phrs.2025.108049_bib53","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"P\u00e9rez-Gonz\u00e1lez","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib54","article-title":"Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity","volume":"21","author":"Lee","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: from mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13046-021-02197-x","article-title":"Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p\/ST6GAL1\/NF-\u03baB pathway","volume":"41","author":"Mei","year":"2022","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib57","article-title":"The miR-33a-5p\/CROT axis mediates ovarian cancer cell behaviors and chemoresistance via the regulation of the TGF-\u03b2 signal pathway","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.phrs.2025.108049_bib58","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1158\/0008-5472.CAN-22-0717","article-title":"DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma","volume":"82","author":"Nan","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2025.108049_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101245","article-title":"Long non-coding RNA LRTOR drives osimertinib resistance in non-small cell lung cancer by boosting YAP positive feedback loop","volume":"83","author":"Miao","year":"2025","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.phrs.2025.108049_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of Multidrug Resistance in Cancer Chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib61","first-page":"1103","article-title":"Cholesterol metabolism in drug\u2011resistant cancer (Review)","volume":"57","author":"Yan","year":"2020","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215798","article-title":"LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling","volume":"543","author":"Yang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2025.108049_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib64","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in Cancer","volume":"16","author":"He","year":"2020","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41419-025-07374-w","article-title":"Long noncoding RNA GDIL acts as a scaffold for CHAC1 and XRN2 to promote platinum resistance of colorectal cancer through inhibition of glutathione degradation","volume":"16","author":"Deng","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib66","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-23-3748","article-title":"MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer","volume":"85","author":"Qu","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2025.108049_bib67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41419-021-03523-z","article-title":"Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p\/HIF-1\u03b1 negative feedback loop in melanoma","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100960","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.phrs.2025.108049_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1300","article-title":"Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation","volume":"13","author":"Shi","year":"2023","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41418-022-01049-1","article-title":"A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3","volume":"30","author":"Zhou","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2025.108049_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217909","article-title":"Autophagy paradox: Genetic and epigenetic control of autophagy in cancer progression","volume":"630","author":"Bhol","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2025.108049_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1158\/0008-5472.CAN-21-3432","article-title":"Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma","volume":"83","author":"Pan","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2025.108049_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204513","article-title":"A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy","volume":"9","author":"Pan","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib75","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molmed.2023.07.003","article-title":"Cancer quiescence: non-coding RNAs in the spotlight","volume":"29","author":"Soureas","year":"2023","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41419-025-07887-4","article-title":"Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma","volume":"16","author":"Kabir","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib78","article-title":"MicroRNAs and Apoptosis in Colorectal Cancer","volume":"21","author":"Wang","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib79","article-title":"APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib80","article-title":"Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer","volume":"256","author":"Zamarbide","year":"2023","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.phrs.2025.108049_bib81","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.phrs.2025.108049_bib82","first-page":"1050","article-title":"MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-\u03baB","volume":"21","author":"Sun","year":"2024","journal-title":"Cancer Biol. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib83","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41419-024-07278-1","article-title":"LOC730101 improves ovarian cancer drug sensitivity by inhibiting autophagy-mediated DNA damage repair via BECN1","volume":"15","author":"Zhong","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib84","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41419-024-07133-3","article-title":"Loss of miR-200c-3p promotes resistance to radiation therapy via the DNA repair pathway in prostate cancer","volume":"15","author":"Labb\u00e9","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-024-02217-2","article-title":"Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance","volume":"24","author":"Zhao","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.phrs.2025.108049_bib87","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2025.108049_bib88","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.ymthe.2021.04.028","article-title":"Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer","volume":"29","author":"Ning","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.108049_bib89","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13046-022-02505-z","article-title":"Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1","volume":"41","author":"Gao","year":"2022","journal-title":"J. Exp. Clin. Canc Res."},{"key":"10.1016\/j.phrs.2025.108049_bib90","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1186\/s12967-024-05797-1","article-title":"miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1","volume":"22","author":"Choi","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2025.108049_bib91","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.7150\/thno.82590","article-title":"SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages","volume":"13","author":"Fan","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2025.108049_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004832","article-title":"Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance","volume":"10","author":"Cheng","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib93","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12943-024-02203-8","article-title":"Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity","volume":"24","author":"Can","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib94","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12943-024-02116-6","article-title":"Exosomal miR-4745-5p\/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12943-024-02201-w","article-title":"The miR-23a\/27a\/24\u2009-\u20092 cluster drives immune evasion and resistance to PD-1\/PD-L1 blockade in non-small cell lung cancer","volume":"23","author":"Luo","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib96","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41419-024-06791-7","article-title":"The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma","volume":"15","author":"Pathania","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib97","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13046-022-02478-z","article-title":"Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1\/DPP4 axis in hepatocellular carcinoma","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113168","article-title":"Drug-resistant exosome miR-99b-3p induces macrophage polarization and confers chemoresistance on sensitive cells by targeting PPP2CA","volume":"142","author":"Mao","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2025.108049_bib99","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s42003-025-08441-w","article-title":"Exo-miR-1911-5p regulates ferroptosis to promote macrophages M2 polarization-mediated gastric cancer cisplatin resistance via MYB\/AKR1B10\/ACC","volume":"8","author":"Kong","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.phrs.2025.108049_bib100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","article-title":"Stromal cells in the tumor microenvironment: accomplices of tumor progression?","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib101","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1186\/s12967-025-06794-8","article-title":"Hypoxic cancer-associated fibroblast exosomal circSTAT3 drives triple negative breast cancer stemness via miR-671-5p\/NOTCH1 signaling","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12943-025-02385-9","article-title":"CircERC1 facilitates chemoresistance through inhibiting pyroptosis and remodeling extracellular matrix in pancreatic cancer","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib103","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","article-title":"Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202506674","article-title":"Exosomal CCT6A secreted by cancer-associated fibroblasts interacts with \u03b2-catenin to enhance chemoresistance and tumorigenesis in gastric cancer","volume":"12","author":"Sun","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101275","article-title":"Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer","volume":"82","author":"Xu","year":"2025","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.phrs.2025.108049_bib106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12951-023-01997-x","article-title":"Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21\/SP1\/DNMT1 positive feedback loop","volume":"21","author":"Qiu","year":"2023","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.phrs.2025.108049_bib107","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/ars.2024.0882","article-title":"Exosomal miR-196a-5p secreted by bone marrow mesenchymal stem cells inhibits ferroptosis and promotes drug resistance of acute myeloid leukemia","volume":"42","author":"Fan","year":"2025","journal-title":"Antioxid. Redox Sign"},{"key":"10.1016\/j.phrs.2025.108049_bib108","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13046-021-02209-w","article-title":"Induction of m(6)A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib109","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12964-024-01806-4","article-title":"Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer","volume":"22","author":"Williams","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.phrs.2025.108049_bib110","article-title":"Linking tumour angiogenesis and tumour immunity","author":"Kabir","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.108049_bib111","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1158\/1078-0432.CCR-23-2748","article-title":"Circulating microRNA analysis in a prospective Co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer","volume":"30","author":"Hedayat","year":"2024","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2025.108049_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100975","article-title":"lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2","volume":"69","author":"Wen","year":"2023","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.phrs.2025.108049_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102194","article-title":"miR-200-mediated inactivation of cancer-associated fibroblasts via targeting of NRP2-VEGFR signaling attenuates lung cancer invasion and metastasis","volume":"35","author":"Cheon","year":"2024","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.phrs.2025.108049_bib114","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41419-021-04024-9","article-title":"Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2","volume":"12","author":"Kim","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13046-021-02143-x","article-title":"Lnc-RP11-536\u2009K7.3\/SOX2\/HIF-1\u03b1 signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Canc Res"},{"key":"10.1016\/j.phrs.2025.108049_bib116","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-021-01133-y","article-title":"Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML","volume":"14","author":"Zhang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib117","first-page":"3945","article-title":"MicroRNA-205-5p targets the HOXD9-Snail1 axis to inhibit triple negative breast cancer cell proliferation and chemoresistance","volume":"13","author":"Lin","year":"2021","journal-title":"Aging (Albany Ny. )"},{"key":"10.1016\/j.phrs.2025.108049_bib118","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.gendis.2019.12.012","article-title":"All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members","volume":"8","author":"Cui","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib119","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2373497","article-title":"MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3","volume":"25","author":"Peng","year":"2024","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phrs.2025.108049_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103488","article-title":"MiR-624-5p enhances NLRP3 augmented gemcitabine resistance via EMT\/IL-1beta\/Wnt\/beta-catenin signaling pathway in ovarian cancer","volume":"150","author":"Alrashed","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.phrs.2025.108049_bib121","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-6632.1983.tb47317.x","article-title":"Comparison of dimethyl sulfoxide levels in whole blood and serum using an autosampler-equipped gas chromatograph","volume":"411","author":"Garretson","year":"1983","journal-title":"Ann. Ny. Acad. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib122","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1159\/000482025","article-title":"Astragaloside IV induced miR-134 expression reduces EMT and increases chemotherapeutic sensitivity by suppressing CREB1 signaling in colorectal cancer cell line SW-480","volume":"43","author":"Ye","year":"2017","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.phrs.2025.108049_bib123","doi-asserted-by":"crossref","first-page":"27343","DOI":"10.1074\/jbc.M113.490482","article-title":"Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines","volume":"288","author":"Kang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.108049_bib124","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1248\/bpb.b23-00668","article-title":"Icariin regulates EMT and stem cell-like character in breast cancer through modulating lncRNA NEAT1\/TGF\u03b2\/SMAD2 signaling pathway","volume":"47","author":"Song","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2025.108049_bib125","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1080\/15384101.2020.1838791","article-title":"Matrine Inhibitory Effect on Self-renewal and Re-sensitization of 5-FU Resistant NSCLC Stem Cells were through Let-7b dependent Downregulation of CCND1","volume":"19","author":"Li","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phrs.2025.108049_bib126","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11655-017-2279-1","article-title":"Babaodan Capsule combined with Qingyi Huaji Formula in advanced pancreatic cancer-a feasibility study","volume":"23","author":"Song","year":"2017","journal-title":"Chin. J. Integr. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib127","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190610","article-title":"Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630\/miR-373\/EphB2-NANOG signals","volume":"39","author":"Chen","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.phrs.2025.108049_bib128","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jcmm.13970","article-title":"The contrary functions of lncRNA HOTAIR\/miR-17-5p\/PTEN axis and Shenqifuzheng injection on chemosensitivity of gastric cancer cells","volume":"23","author":"Jia","year":"2019","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41419-018-0277-7","article-title":"BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells","volume":"9","author":"Kwon","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108049_bib130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.15283\/ijsc20157","article-title":"Bie Jia jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells","volume":"14","author":"Jingjing","year":"2021","journal-title":"Int J. Stem Cells"},{"key":"10.1016\/j.phrs.2025.108049_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154571","article-title":"Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195\/ERK\/\u03b2-catenin pathway","volume":"109","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.108049_bib132","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1159\/000430270","article-title":"Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93\/PTEN\/Akt signaling pathway","volume":"36","author":"Chen","year":"2015","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.phrs.2025.108049_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1613560","article-title":"The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotype and gemcitabine chemoresistance via miR-188-5p\/CDCA3\/TRAF2-mediated remodeling of NF-\u03baB signaling pathway","volume":"16","author":"Ji","year":"2025","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib134","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12967-023-04483-y","article-title":"Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib135","first-page":"18191","article-title":"Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195\/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer","volume":"13","author":"Wu","year":"2021","journal-title":"Aging (Albany Ny. )"},{"key":"10.1016\/j.phrs.2025.108049_bib136","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.21873\/anticanres.17362","article-title":"Effects of curcumin and its analogue desmethoxycurcumin on miR-133b and its target gene GSTP-1 in Cisplatin-resistant Ovarian Cancer Cells","volume":"44","author":"\u00dclker","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2025.108049_bib137","first-page":"23096","article-title":"Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10\/miR-1271-5p\/TRIM66 axis","volume":"13","author":"Cao","year":"2021","journal-title":"Aging (Albany Ny. )"},{"key":"10.1016\/j.phrs.2025.108049_bib138","first-page":"17202","article-title":"Zhoushi Qiling decoction induces apoptosis of human prostate cancer cells via miR-143\/Bcl-2 axis","volume":"13","author":"Cao","year":"2021","journal-title":"Aging (Albany Ny. )"},{"key":"10.1016\/j.phrs.2025.108049_bib139","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.phymed.2014.04.006","article-title":"Propolis cinnamic acid derivatives induce apoptosis through both extrinsic and intrinsic apoptosis signaling pathways and modulate of miRNA expression","volume":"21","author":"Kumazaki","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.108049_bib140","article-title":"6'-O-galloylpaeoniflorin exerts inhibitory bioactivities in human neuroblastoma cells via modulating AMPK\/miR-489\/XIAP pathway","volume":"2022","author":"Zhou","year":"2022","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.phrs.2025.108049_bib141","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s11626-016-0044-y","article-title":"Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203","volume":"52","author":"You","year":"2016","journal-title":"Vitr. Cell Dev."},{"key":"10.1016\/j.phrs.2025.108049_bib142","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jnutbio.2013.04.006","article-title":"Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells","volume":"24","author":"Kumazaki","year":"2013","journal-title":"J. Nutr. Biochem"},{"key":"10.1016\/j.phrs.2025.108049_bib143","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.1002\/jsfa.13718","article-title":"Terpenoids from quinoa reverse drug resistance of colon cancer by upregulating miR-495-3p","volume":"104","author":"Feng","year":"2024","journal-title":"J. Sci. Food Agr."},{"key":"10.1016\/j.phrs.2025.108049_bib144","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5953619","article-title":"Spica prunellae extract enhances fluorouracil sensitivity of 5-fluorouracil-resistant human colon carcinoma HCT-8\/5-FU Cells via TOP2\u03b1 and miR-494","volume":"2019","author":"Fang","year":"2019","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.phrs.2025.108049_bib145","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.3390\/ijms150814298","article-title":"Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression","volume":"15","author":"Zuo","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib146","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/09553002.2024.2324475","article-title":"Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX-2\/PGE2\/JAK2\/STAT3\/MMP pathway","volume":"100","author":"Wang","year":"2024","journal-title":"Int J. Radiat. Biol."},{"key":"10.1016\/j.phrs.2025.108049_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117547","article-title":"Maimendong and Qianjinweijing Tang combined with cisplatin suppressed lung cancer through targeting lncRNA-p21","volume":"322","author":"Xie","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2025.108049_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112836","article-title":"Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p","volume":"258","author":"Jiang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2025.108049_bib149","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1142\/S0192415X22500719","article-title":"Tangeretin Synergizes with 5-Fluorouracil to Induce Autophagy through MicroRNA-21 in Colorectal Cancer Cells","volume":"50","author":"Bai","year":"2022","journal-title":"Am. J. Chin. Med"},{"key":"10.1016\/j.phrs.2025.108049_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116688","article-title":"Autophagy modulation in cancer therapy: challenges coexist with opportunities","volume":"276","author":"Wu","year":"2024","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.phrs.2025.108049_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156137","article-title":"EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p","volume":"135","author":"Yi","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.108049_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156390","article-title":"Bushen Jiedu formula alleviates colorectal cancer progression through reducing lncRPPH1 in tumor-derived extracellular vesicles","volume":"138","author":"Shao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.108049_bib153","article-title":"Therapeutic effect and mechanism of bushen-jianpi-jiedu decoction combined with chemotherapeutic drugs on postoperative colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153797","article-title":"Gamma-mangostin isolated from Garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3\u03b2\/\u03b2-catenin\/CDK6 cancer stem pathway","volume":"95","author":"Wu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.108049_bib155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1476-4598-9-268","article-title":"Increased accumulation of hypoxia-inducible factor-1\u03b1 with reduced transcriptional activity mediates the antitumor effect of triptolide","volume":"9","author":"Zhou","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib156","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fphar.2019.00515","article-title":"Bioactive ingredients in Chinese herbal medicines that target non-coding RNAs: promising new choices for disease treatment","volume":"10","author":"Dong","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054476","article-title":"Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials","volume":"24","author":"Panknin","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib158","article-title":"Drug repurposing in traditional Chinese medicine: from empirical wisdom to modern therapeutic strategies","volume":"16","author":"Wu","year":"2025","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib159","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.3390\/ijms150814298","article-title":"Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression","volume":"15","author":"Zuo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108049_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1448381","article-title":"Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma","volume":"15","author":"Ma","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib161","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/EBC20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays Biochem"},{"key":"10.1016\/j.phrs.2025.108049_bib162","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/09731296231203458","article-title":"Research advancements in pharmacological activities and mechanisms of matrine","volume":"20","author":"Chen","year":"2024","journal-title":"Pharm. Mag."},{"key":"10.1016\/j.phrs.2025.108049_bib163","article-title":"Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib164","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phrs.2025.108049_bib165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib166","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108049_bib167","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2025.108049_bib168","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40364-024-00643-4","article-title":"Single-cell sequencing to multi-omics: technologies and applications","volume":"12","author":"Wu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.phrs.2025.108049_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-018-0007-6","article-title":"H.C. Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib170","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2025.108049_bib171","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.2147\/IJN.S502104","article-title":"Harnessing the power of traditional chinese medicine in cancer treatment: the role of nanocarriers","volume":"20","author":"Fu","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2025.108049_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and Challenges of Liposome Assisted Drug Delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib173","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd1088","article-title":"The dawning era of polymer therapeutics","volume":"2","author":"Duncan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2025.108049_bib174","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biomaterials.2018.10.012","article-title":"Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs","volume":"188","author":"Mao","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2025.108049_bib175","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","author":"Maeda","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2025.108049_bib176","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Dan Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.phrs.2025.108049_bib177","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib178","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.biomaterials.2013.12.090","article-title":"Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment","volume":"35","author":"Naksuriya","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2025.108049_bib179","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2015.01.003","article-title":"Resveratrol nanoformulations: Challenges and opportunities","volume":"479","author":"Summerlin","year":"2015","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.phrs.2025.108049_bib180","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Jessica Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2025.108049_bib181","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12943-024-02135-3","article-title":"Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.108049_bib182","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12943-025-02416-5","article-title":"Traditional Chinese medicine in the treatment of breast Cancer","volume":"24","author":"Song","year":"2025","journal-title":"Mol. Cancer"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:45:11Z","timestamp":1778795111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":182,"alternative-id":["S1043661825004748"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108049","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Chinese medicines in targeting non-coding RNAs to overcome cancer drug resistance: Mechanisms and clinical translation challenges","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108049"}}